<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Arbutus Biopharma Corporation

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Arbutus Biopharma Corporation

    Arbutus Biopharma is a publicly-traded (NASDAQ:ABUS) biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). We are developing a portfolio of drug candidates with multiple mechanisms of action that we believe will result in a combination therapy that will transform the HBV treatment landscape and cure hepatitis B virus disease. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      William H. Collier
    • FOUNDED
      1992
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Anika Therapeutics Inc.

    Anika Therapeutics Inc.

    Headquartered in Bedford, Massachusetts, Anika Therapeutics, Inc. develops, manufa...

    Headquartered in Bedford, Massachusetts, Anika ...

    Filing Type:    PU
    CareDx, Inc.

    CareDx, Inc.

    CareDx, Inc., headquartered in Brisbane, California, is a molecular diagnostics co...

    CareDx, Inc., headquartered in Brisbane, Califo...

    Filing Type:    PU
    MediWound Ltd.

    MediWound Ltd.

    MediWound is a fully integrated biopharmaceutical company focused on developing, m...

    MediWound is a fully integrated biopharmaceutic...

    Filing Type:    PU
    Geron Corporation

    Geron Corporation

    Geron is a late-stage clinical biopharmaceutical company focused on the developmen...

    Geron is a late-stage clinical biopharmaceutica...

    Filing Type:    PU
    Syros Pharmaceuticals, Inc.

    Syros Pharmaceuticals, Inc.

    Syros is redefining the power of small molecules to control the expression of gene...

    Syros is redefining the power of small molecule...

    Filing Type:    PU
    aTyr Pharma, Inc.

    aTyr Pharma, Inc.

    aTyr’s mission is to translate newly discovered biological pathways to develop i...

    aTyr’s mission is to translate newly discover...

    Filing Type:    PU
    VBI Vaccines, Inc.

    VBI Vaccines, Inc.

    VBI Vaccines Inc. (Nasdaq: VBIV) is a commercial-stage biopharmaceutical company d...

    VBI Vaccines Inc. (Nasdaq: VBIV) is a commercia...

    Filing Type:    PU
    Spring Bank Pharmaceuticals, Inc.

    Spring Bank Pharmaceuticals, Inc.

    Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery...

    Spring Bank is a clinical-stage biopharmaceutic...

    Filing Type:    PU
    Assembly Biosciences, Inc.

    Assembly Biosciences, Inc.

    Assembly Biosciences is advancing a new class of oral therapeutics for the treatme...

    Assembly Biosciences is advancing a new class o...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.